Recombinant Anti-Insulin Antibody (V3S-0723-FY158) (CAT#: V3S-0723-FY158)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody was established from three IDDM patients treated with human recombinant insulin by EBV transformation and somatic cell hybridization. The mAb has an affinity of 0.5 μM for homologous insulin.
Clonality Monoclonal
Host Species Human
Target Species Human
Immunogen Human recombinant insulin protein
Affinity 0.5 μM
Isotype IgG1, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target Insulin
Alternative Name Insulin
Research Area Signal Pathway
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry